JP2002526407A5 - - Google Patents

Download PDF

Info

Publication number
JP2002526407A5
JP2002526407A5 JP2000573359A JP2000573359A JP2002526407A5 JP 2002526407 A5 JP2002526407 A5 JP 2002526407A5 JP 2000573359 A JP2000573359 A JP 2000573359A JP 2000573359 A JP2000573359 A JP 2000573359A JP 2002526407 A5 JP2002526407 A5 JP 2002526407A5
Authority
JP
Japan
Prior art keywords
derivative
ester
salt
pharmaceutical composition
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000573359A
Other languages
English (en)
Japanese (ja)
Other versions
JP4700808B2 (ja
JP2002526407A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB1999/001649 external-priority patent/WO2000019999A1/en
Publication of JP2002526407A publication Critical patent/JP2002526407A/ja
Publication of JP2002526407A5 publication Critical patent/JP2002526407A5/ja
Application granted granted Critical
Publication of JP4700808B2 publication Critical patent/JP4700808B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000573359A 1998-10-08 1999-10-08 フルボ酸、および種々の状態の処置におけるその使用 Expired - Fee Related JP4700808B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ZA989190 1998-10-08
ZA98/9190 1998-10-08
ZA99/2848 1999-04-21
ZA992848 1999-04-21
PCT/IB1999/001649 WO2000019999A1 (en) 1998-10-08 1999-10-08 Fulvic acid and its use in the treatment of various conditions

Publications (3)

Publication Number Publication Date
JP2002526407A JP2002526407A (ja) 2002-08-20
JP2002526407A5 true JP2002526407A5 (enExample) 2006-11-30
JP4700808B2 JP4700808B2 (ja) 2011-06-15

Family

ID=27144980

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000573359A Expired - Fee Related JP4700808B2 (ja) 1998-10-08 1999-10-08 フルボ酸、および種々の状態の処置におけるその使用

Country Status (7)

Country Link
US (1) US6569900B1 (enExample)
EP (4) EP1126837B1 (enExample)
JP (1) JP4700808B2 (enExample)
AT (4) ATE410158T1 (enExample)
AU (1) AU766198B2 (enExample)
DE (4) DE69939721D1 (enExample)
WO (1) WO2000019999A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2570565C (en) * 2004-06-23 2012-10-23 Bioz Agri Products Inc. Method for extracting fulvic acid molecules
RU2280458C1 (ru) * 2004-11-30 2006-07-27 Алевтина Ивановна Косолапова Противовоспалительная мазь
ZA200705844B (en) * 2004-12-15 2008-09-25 Van Der Westhuzen Corne Floris Detoxifying and immunity-booster composition
US20080160111A1 (en) * 2005-02-28 2008-07-03 Hiroko Isoda Type I Allergy Inhibitor and Methods of Inhibiting the Onset of Type I Allergy Using Fulvic Acid
JP2006232785A (ja) * 2005-02-28 2006-09-07 Univ Of Tsukuba フルボ酸を用いるｉ型アレルギー抑制剤及びｉ型アレルギーの発症抑制方法。
US20070212434A1 (en) * 2006-03-07 2007-09-13 Day Kenneth S Compositions and methods for human use containing fulvic acid
WO2007125492A2 (en) * 2006-05-02 2007-11-08 Pfeinsmith S.A. (Pty) Ltd Acidic composition
US8445452B2 (en) 2008-06-05 2013-05-21 Pfeinsmith Ltd. Fulvic acid and antibiotic combination
DE102008058552A1 (de) 2008-11-21 2010-05-27 Mankau, Dieter, Prof. Dr. Federrahmen und Federkörper zur Abstützung z. B. einer Matratze
GB0900786D0 (en) 2009-01-19 2009-03-04 Natracine Uk Ltd Therapeutic compositions
GB0914966D0 (en) 2009-08-27 2009-09-30 Natracine Uk Ltd Fulvic acid compositions and their use
WO2013023062A1 (en) * 2011-08-09 2013-02-14 Wilford Lynn C Antimicrobial agents and methods for use thereof in the abatement of food borne pathogenic organisms
CN104203227A (zh) 2012-03-07 2014-12-10 南彻森英国有限公司 用于抑制或治疗多重耐药细菌的富里酸与抗生素组合物
EP3004070B1 (en) 2013-05-28 2017-10-11 Empire Technology Development LLC Antioxidant humic acid derivatives and methods of preparation and use
EP3004069B1 (en) 2013-05-28 2017-04-19 Empire Technology Development LLC Humic acid derivatives and methods of preparation and use
WO2014209369A1 (en) 2013-06-28 2014-12-31 Empire Technology Development Llc Edible plasticizers for food and food packaging films
WO2017102565A1 (en) * 2015-12-15 2017-06-22 Rita Dobmeyer Pharmaceutical composition comprising a fulvic acid and at least one boron-containing compound
US9820953B2 (en) 2016-02-26 2017-11-21 Omni Bioceutical Innovations, Inc. Compositions of bioactive fulvate fractions and uses thereof
JP6120342B1 (ja) * 2016-03-08 2017-04-26 株式会社スタイルアンドバリュージャパン 美容組成物
US20220160649A1 (en) * 2019-03-20 2022-05-26 Rita DOBMEYER Pharmaceutical composition
EP3799854A1 (en) 2019-10-01 2021-04-07 Stefan Johannes Fellner Extract of organic humified materials
US20230165918A1 (en) * 2020-05-05 2023-06-01 Figene, Llc Reduction of cytokine storm and pathological inflammation including caused by coronavirus using sphagnum and extracts thereof
KR102258006B1 (ko) * 2020-12-22 2021-05-28 허교 풀빅산을 유효성분으로 포함하는 항바이러스 조성물
CN117064913A (zh) * 2023-02-23 2023-11-17 单士军 用于缓解特应性皮炎的黄腐酸外用制剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB244215A (en) 1924-10-09 1925-12-17 Richard William Bailey Improvements in or relating to gas or oil power plant
DE2850685A1 (de) * 1978-11-22 1980-06-04 Kneer Franz X Verfahren zur herstellung eines kolloiden schlammbades und schlammartiger pasten fuer die heilbehandlung
US5204368A (en) * 1990-05-25 1993-04-20 National Energy Council Bacteriostatic and bacteriocidal method using fulvic acid derivatives
JPH0466508A (ja) * 1990-07-03 1992-03-02 Suntory Ltd 抗菌剤
JPH0687752A (ja) * 1992-09-04 1994-03-29 Kyowa Kagaku Kogyo Kk 抗菌水及びこの抗菌水の製造方法
CN1097990A (zh) * 1994-01-29 1995-02-01 康宏盛 一种治疗股癣的药物
JPH1017483A (ja) * 1996-06-26 1998-01-20 Keinzu Corp:Kk 皮膚疾患予防及び治療剤
EP0907624A1 (en) * 1996-06-27 1999-04-14 Organoflo (Proprietary) Limited A method of making a liquid fertilizing substance
JPH119674A (ja) 1997-06-25 1999-01-19 M S K Planning:Kk フミン酸を有効成分とする液体消臭剤と、その製造方法及びフミン酸を有効成分とした飲料用消臭剤と、その製造方法
CN1103339C (zh) * 1998-08-25 2003-03-19 祝亚勤 药用级泥炭黄腐植酸钠的制备方法

Similar Documents

Publication Publication Date Title
JP2002526407A5 (enExample)
EP0506207B1 (en) Pharmaceutical vehicles for reducing transdermal flux
ES2323395T3 (es) Procedimiento y composicion para el tratamiento de irritaciones e infecciones epidermicas.
CN101687002B (zh) 葫芦巴的提取物
ATE401089T1 (de) Orale zubereitungen, die antimikrobielle wirkstoffe enthalten zur prävention von systemischen erkrankungen
US9662360B2 (en) Treatment of herpes, pseudomonas, staph, and hepatitis
JP2002524415A5 (enExample)
ATE455539T1 (de) Darreichungsformen mit verlängerter wirkstofffreisetzung
BR9807319A (pt) Microgrânulos com liberação controlada, para administração oral, contendo cisplatina, processo de preparação dos mesmos, preparação farmacêutica, e, utilização dos microgrânulos.
RU2012149863A (ru) Полисахарид семени тамаринда для применения в лечении микробных инфекций
DE69932939D1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
JP2010536745A5 (enExample)
JP2022520665A (ja) 液体プロポリス抽出物、その製剤およびその使用
CN105431154A (zh) 抗菌成分
JP2009534306A5 (enExample)
EP1852114A4 (en) COMPOSITION WITH DIHOMO (GAMMA) LINE ACIDIC ACID (DGLA) AS AN ACTIVE INGREDIENTS
CN105125445B (zh) 一种牙膏组合物
CN107582943B (zh) 一种防治动物疥螨病的复方中药透皮喷雾剂及制备方法
ME02149B (me) FORMULACIJE l METODE ZA LEČENJE AMILOIDOZE
CN101259149A (zh) 治疗脚气的酊剂
WO2000016786A3 (en) Oxihumic acid and its use in the treatment of various conditions
Semkina Ointments, gels, liniments, and creams containing phytopreparations (a review)
WO2001045727A3 (en) Stabilized veterinary compositions comprising more than one antiviral agent
JP2014524454A (ja) 乾燥抽出物の製造方法
JP2004500315A5 (enExample)